OLR1 and malignant colon neoplasm: We have found that 15-LOX-1 markedly inhibited the survival of not only HCT116 cells that were derived from primary colon tumors but also colon cancer cells metastatic origin (LoVo) 47 and those selected in preclinical models for higher metastatic potential (HT29LMM) 48.